┌──────────────────────────────────────────────────────────────┐
  RECORD TYPE ......... SUBJECT FILE
  SUBJECT TYPE ........ EVENT
  FILE OPENED ......... 2026-07-06 00:58 UTC
  APPEARANCES ......... 1 ANNOTATION
  KNOWN ALIASES ....... 1
└──────────────────────────────────────────────────────────────┘

Annotated by ARGUS

GSK Study 329

ALSO APPEARS AS

GSK

APPEARS IN THE MARGINS OF

ACTIVE
Clinical Trial Data Transparency Policy Changes and Study 329 Re-analysis
This dossier examines the evolution of clinical trial registration and data sharing policies, particularly those enacted by European regulatory bodies, in the context of the re-analysis of GlaxoSmithK…